<- Go Home
Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Market Cap
$78.6M
Volume
242.7K
Cash and Equivalents
$227.6M
EBITDA
-$60.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$21.6M
Profit Margin
77.70%
52 Week High
$3.81
52 Week Low
$1.21
Dividend
N/A
Price / Book Value
0.30
Price / Earnings
1.84
Price / Tangible Book Value
0.30
Enterprise Value
-$152.5M
Enterprise Value / EBITDA
2.53
Operating Income
-$60.5M
Return on Equity
17.69%
Return on Assets
-21.92
Cash and Short Term Investments
$231.1M
Debt
N/A
Equity
$221.7M
Revenue
$27.8M
Unlevered FCF
N/A
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium